Next Article in Journal
Breast Cancer Risk Assessment and Primary Prevention Advice in Primary Care: A Systematic Review of Provider Attitudes and Routine Behaviours
Next Article in Special Issue
A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer
Previous Article in Journal
Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma
Previous Article in Special Issue
The Present and Future of Neoadjuvant Endocrine Therapy for Breast Cancer Treatment
Article

Hypnosis Sedation Reduces the Duration of Different Side Effects of Cancer Treatments in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

1
Breast Clinic, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, 1200 Woluwe-Saint-Lambert, Belgium
2
Department of Oncology Cliniques Saint-Pierre, 1340 Ottignies, Belgium
3
Department of Gynaecology, Hôpital de Jolimont, 7100 La Louvière, Belgium
4
Department of Anesthesiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, 1340 Ottignies-Louvain-la-Neuve, Belgium
5
Medical and Financial Department, Grand Hôpital de Charleroi, 6000 Charleroi, Belgium
*
Author to whom correspondence should be addressed.
Academic Editors: Andrea Nicolini, Samuel Cos and Theodoros Foukakis
Cancers 2021, 13(16), 4147; https://doi.org/10.3390/cancers13164147
Received: 26 June 2021 / Revised: 25 July 2021 / Accepted: 13 August 2021 / Published: 18 August 2021
(This article belongs to the Special Issue Neoadjuvant Therapy in Breast Cancer)
Reducing side effects of cancer treatments is a major challenge for clinicians involved in the management of breast cancer patients. Among patients receiving neoadjuvant chemotherapy followed by surgery, radiotherapy and endocrine therapy, prolonged side effects frequently mentioned are: polyneuropathy, musculoskeletal pain, postoperative pain and cancer-related fatigue. Conventional drugs have proven to be ineffective in treating theses effects, except for postoperative pain. This is the reason why we prospectively tested the impact of hypnosis sedation used as anesthetic technique for breast cancer surgery on the different side effects of cancer treatment. Despite the limitations of this small non-randomized cohort, preliminary results are very encouraging.
Background: Reducing side effects of cancer treatments is a major challenge for clinicians involved in the management of breast cancer patients. Methods: We analyzed data from 63 patients (32 in the general anesthesia group and 31 in the hypnosis sedation group) who were included in 1 prospective non-randomized trial evaluating hypnosis sedation in breast cancer treatment. The patients were followed every 3 months for 2 years. All patients received neoadjuvant chemotherapy with 4 cycles of epirubicin and cyclophosphamide followed by taxanes. Thereafter, patients underwent surgery while on general anesthesia or while on hypnosis sedation. Radiotherapy was administered according to institutional guidelines. Endocrine therapy was prescribed if tumors expressed hormone receptors. Prevalence, intensity and duration of polyneuropathy, musculoskeletal pain, postoperative pain and cancer-related fatigue were assessed at each medical visit. Results: Symptoms duration was statistically reduced for polyneuropathy (p < 0.05), musculoskeletal pain (p < 0.05) postoperative pain and cancer-related fatigue (p < 0.05) in the hypnosis group. Conclusion: Despite the limitations of this study (lack of randomization and small size) we conclude that hypnosis sedation may exert a role on different side effects of breast cancer treatment in patients receiving neoadjuvant chemotherapy, mainly by reducing their duration. View Full-Text
Keywords: polyneuropathy; postoperative pain; musculoskeletal pain; cancer-related fatigue; neoadjuvant chemotherapy; hypnosis sedation polyneuropathy; postoperative pain; musculoskeletal pain; cancer-related fatigue; neoadjuvant chemotherapy; hypnosis sedation
Show Figures

Figure 1

MDPI and ACS Style

Berliere, M.; Piette, N.; Bernard, M.; Lacroix, C.; Gerday, A.; Samartzi, V.; Coyette, M.; Roelants, F.; Docquier, M.-A.; Touil, N.; Watremez, C.; Piette, P.; Duhoux, F.P. Hypnosis Sedation Reduces the Duration of Different Side Effects of Cancer Treatments in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancers 2021, 13, 4147. https://doi.org/10.3390/cancers13164147

AMA Style

Berliere M, Piette N, Bernard M, Lacroix C, Gerday A, Samartzi V, Coyette M, Roelants F, Docquier M-A, Touil N, Watremez C, Piette P, Duhoux FP. Hypnosis Sedation Reduces the Duration of Different Side Effects of Cancer Treatments in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancers. 2021; 13(16):4147. https://doi.org/10.3390/cancers13164147

Chicago/Turabian Style

Berliere, Martine, Nathan Piette, Marion Bernard, Camille Lacroix, Amandine Gerday, Vasiliki Samartzi, Maude Coyette, Fabienne Roelants, Marie-Agnes Docquier, Nassim Touil, Christine Watremez, Philippe Piette, and Fran×ois P. Duhoux. 2021. "Hypnosis Sedation Reduces the Duration of Different Side Effects of Cancer Treatments in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy" Cancers 13, no. 16: 4147. https://doi.org/10.3390/cancers13164147

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop